Jiangsu Bioperfectus Technologies Co., Ltd. — Investor Relations & Filings
About Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd. specializes in the research, development, and manufacturing of molecular diagnostic solutions. The company provides a comprehensive portfolio of products, including real-time PCR diagnostic kits, automated nucleic acid extraction systems, and rapid test reagents. Its primary focus lies in the detection of infectious diseases, such as respiratory infections, sexually transmitted diseases, and vector-borne illnesses. Bioperfectus serves clinical laboratories, public health institutions, and research facilities. The company provides integrated laboratory workflows designed to enhance diagnostic efficiency and accuracy. Key product lines include solutions for HPV screening, influenza monitoring, and emerging pathogen detection, supported by high-throughput diagnostic platforms.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 江苏硕世生物科技股份有限公司获得政府补助的公告 | 2026-01-04 | Chinese | |
| 江苏硕世生物科技股份有限公司2026年第一次临时股东会会议材料 | 2025-12-24 | Chinese | |
| 江苏硕世生物科技股份有限公司章程 | 2025-12-15 | Chinese | |
| 江苏硕世生物科技股份有限公司关于召开2026年第一次临时股东会的通知 | 2025-12-15 | Chinese | |
| 江苏硕世生物科技股份有限公司关于增加公司经营范围并修改公司章程的公告 | 2025-12-15 | Chinese | |
| 江苏硕世生物科技股份有限公司关于自愿披露公司产品列入WHO应急使用清单的公告 | 2025-12-07 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 39091236 | 江苏硕世生物科技股份有限公司获得政府补助的公告 | 2026-01-04 | Chinese | ||
|
2025
14 filings
| |||||
| 39091233 | 江苏硕世生物科技股份有限公司2026年第一次临时股东会会议材料 | 2025-12-24 | Chinese | ||
| 39091232 | 江苏硕世生物科技股份有限公司章程 | 2025-12-15 | Chinese | ||
| 39091221 | 江苏硕世生物科技股份有限公司关于召开2026年第一次临时股东会的通知 | 2025-12-15 | Chinese | ||
| 39091210 | 江苏硕世生物科技股份有限公司关于增加公司经营范围并修改公司章程的公告 | 2025-12-15 | Chinese | ||
| 39091204 | 江苏硕世生物科技股份有限公司关于自愿披露公司产品列入WHO应急使用清单的公告 | 2025-12-07 | Chinese | ||
| 39091200 | 江苏硕世生物科技股份有限公司关于实际控制人续签一致行动协议的公告 | 2025-12-05 | Chinese | ||
| 39091197 | 江苏硕世生物科技股份有限公司关于选举职工董事的公告 | 2025-11-11 | Chinese | ||
| 39091189 | 江苏硕世生物科技股份有限公司关于召开2025年第三季度业绩说明会的公告 | 2025-11-11 | Chinese | ||
| 39091171 | 江苏硕世生物科技股份有限公司2025年第二次临时股东大会决议公告 | 2025-11-11 | Chinese | ||
| 39091164 | 上海市通力律师事务所关于江苏硕世生物科技股份有限公司2025年第二次临时股东大会的法律意见书 | 2025-11-11 | Chinese | ||
| 39091103 | 江苏硕世生物科技股份有限公司2025年第二次临时股东大会会议材料 | 2025-10-28 | Chinese | ||
| 39091097 | 招商证券股份有限公司关于江苏硕世生物科技股份有限公司2025年使用闲置募集资金进行现金管理的核查意见 | 2025-10-24 | Chinese | ||
| 39091091 | 江苏硕世生物科技股份有限公司董事会提名委员会工作细则 | 2025-10-24 | Chinese | ||
| 39091085 | 江苏硕世生物科技股份有限公司内幕信息知情人登记制度 | 2025-10-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jiangsu Bioperfectus Technologies Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58400/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58400 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58400 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58400 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58400}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jiangsu Bioperfectus Technologies Co., Ltd. (id: 58400)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.